Mesirow Financial Investment Management, Inc. Novartis Ag Transaction History
Mesirow Financial Investment Management, Inc.
- $4.84 Billion
- Q2 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 4,630 shares of NVS stock, worth $567,684. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,630
Previous 4,673
0.92%
Holding current value
$567,684
Previous $520,000
7.69%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,582Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.31 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.28 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.11 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$927 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$873 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $264B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...